Evidence for different in vitro oligomerization behaviors of synthetic hIAPP obtained from different sources - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Analytical and Bioanalytical Chemistry Année : 2020

Evidence for different in vitro oligomerization behaviors of synthetic hIAPP obtained from different sources

Résumé

Type 2 diabetes is characterized by the aggregation of human islet amyloid polypeptide (hIAPP), from monomer to amyloid deposits that are made of insoluble fibrils. Discrepancies concerning the nature of formed species or oligomerization kinetics among reported in vitro studies on hIAPP aggregation process have been highlighted. In this work, we investigated if the sample itself could be at the origin of those observed differences. To this aim, four hIAPP samples obtained from three different sources or suppliers have been analyzed and compared by ThT fluorescence spectroscopy and by two recently developed techniques, capillary electrophoresis (CE), and ESI-IMS-QToF-MS. Lots provided by the same supplier were shown to be very similar whatever the analytical technique used to characterize them. In contrast, several critical differences could be pointed out for hIAPP provided by different suppliers. We demonstrated that in several samples, some oligomerized peptides (e.g., dimer) were already present upon reception. Purity was also different, and the proneness of the peptide solution to form fibrils in vitro within 24 h could vary considerably from one sample source to another but not from lot to lot of the same source. All those results demonstrate that the initial state of conformation, oligomerization, and quality of the hIAPP can greatly impact the aggregation kinetics, and thus the information provided by these in vitro tests. Finally, a careful selection of the peptide batch and source is mandatory to perform relevant in vitro studies on hIAPP oligomerization and to screen new molecules modulating this pathological process.
Fichier principal
Vignette du fichier
hIAPP_Diabete.pdf (695.23 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03011853 , version 1 (02-12-2020)

Identifiants

Citer

Corentin Berardet, Julia Kaffy, Frédéric Halgand, Guillaume van Der Rest, Sandrine Ongeri, et al.. Evidence for different in vitro oligomerization behaviors of synthetic hIAPP obtained from different sources. Analytical and Bioanalytical Chemistry, 2020, 412 (13), pp.3103-3111. ⟨10.1007/s00216-020-02560-5⟩. ⟨hal-03011853⟩
26 Consultations
92 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More